Methenamine hippurate in the treatment of urinary tract infections.
作者信息
Kasanen A, Mustakallio E, Koskinen E H, Soini V
出版信息
Ann Clin Res. 1974 Oct;6(5):279-84.
PMID:4614694
Abstract
摘要
相似文献
1
Methenamine hippurate in the treatment of urinary tract infections.
Ann Clin Res. 1974 Oct;6(5):279-84.
2
Methenamine hippurate (Hiprex).
Med Lett Drugs Ther. 1968 Jul 26;10(15):58-60.
3
Clinical pharmacology and antibacterial action of methenamine and its salts (mandelate, hippurate and sulfosalicylate).
Med Times. 1969 Feb;97(2):243-51.
4
Drug therapy reviews: methenamine mandelate and methenamine hippurate.
Am J Hosp Pharm. 1979 Nov;36(11):1509-12.
5
A comparative trial of hexamine hippurate and hexamine mandelate in prevention of recurrent infection of the urinary tract.
Practitioner. 1974 Jul;213(1273):97-101.
6
Formaldehyde generation from methenamine salts in spinal cord injury.
Arch Phys Med Rehabil. 1984 May;65(5):257-9.
7
[Laboratory and clinical studies on hippramine].
Nihon Hinyokika Gakkai Zasshi. 1969 Jan;60(1):71-9. doi: 10.5980/jpnjurol1928.60.1_71.
8
[Methamine hippurate--an old antiseptic in a new formula].
Lakartidningen. 1972 Dec 6;69(50):5870-3.
9
[Clinical testing of methenamine hippurate (Hiprex) in the treatment of urinary tract infections].
Lakartidningen. 1973 Dec 5;70(49):4517-9.
10
Antibacterial correlates of urine drug levels of hexamethylenetetramine and formaldehyde.
Invest Urol. 1970 Jul;8(1):21-33.
引用本文的文献
1
Methenamine hippurate for preventing urinary tract infections.
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD003265. doi: 10.1002/14651858.CD003265.pub3.
2
Lack of effect of methenamine in suppression of, or prophylaxis against, chronic urinary infection.
Antimicrob Agents Chemother. 1977 Nov;12(5):625-9. doi: 10.1128/AAC.12.5.625.
Zotero 插件